It can be concluded that either passive or active immunization
against endogenous inhibin have a positive role for increasing FSH secretion, ovarian follicular development and ovulation rats with subsequent augmentation of reproductive fecundity in Iraqi Awassi ewes during non-breeding season.
The most effective way to prevent tetanus is by active immunization
with a tetanus toxoid vaccine.
In adults 18 years of age and older, Prevnar 13 is indicated for active immunization
for the prevention of pneumonia and invasive disease caused by S.
The FLUARIX QUADRIVALENT (Influenza Vaccine) vaccine was previously only approved for active immunization
against influenza A subtype viruses and type B viruses, in persons three three years of age and older.
On this basis, they have developed and commercialized Flublok Quadrivalent vaccine, a recombinant influenza vaccine indicated for active immunization
of adults 18 years of age and older against seasonal influenza.
Prior to the approval, the vaccine was only approved for active immunization
against influenza A subtype viruses and type B viruses in persons 3 years of age and older.
They were also given 0.5ml tetanus toxoid as part of their active immunization
. All the patients were started on diazepam 5-10mg/kg/day, 50% of dose being given i/v, and 50% orally in four divided doses.
FDA for active immunization
to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
Under certain circumstances this may be accomplished by active immunization
, which is one of the most powerful and cost-effective weapons of modern medicine.
Rabipur is used for active immunization
Influenza vaccines are administered for active immunization
against influenza virus.
The SIMPLE Antibody platform is based on the active immunization
of llamas with human disease targets.
As of July 2013, Menveo is registered in more than 50 countries for active immunization
to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y1.
The proposed indication for the vaccine, which combines hepatitis B surface antigen (HBsAg) with a novel adjuvant to enhance the immune response, is for the active immunization
against all known subtypes of the hepatitis B virus in adults aged 18-70 years.
The proposed indication is for the "active immunization
for the prevention of disease in persons 18 years of age and older at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine." The vaccine is administered in two doses about 21 days apart.